Skip to main content

WA MMJ Petition Hearing 6-2-2010 -- whether to add Alzheimer’s, chronic renal failure and neuropathic pain

Submitted by David Borden on
I'm requesting people who can point me to information that might be persuasive Alzheimer's, chronic renal failure or neuropathic pain are conditions for which medical marijuana would be beneficial point me to that information. Research studies, journal articles, health professional statements and such would probably be most effective. Expert witness testimony from litigation could be very useful. Statements from ordinary people who've experienced or observed benefits or indications of benefits should also be useful. I'm also requesting Washington State residents or health care professionals from anywhere to submit written comments on the matter. Denial of access to medicine is the bias of the agencies that will be making the decision and marijuana is a particularly disfavored medicine. All possible aid is important. All that is necessary for the triumph of evil is that good people do nothing. MEDICAL MARIJUANA PETITION HEARING NOTICE ANNOUNCING LOCATION OF HEARING A committee of the Medical Quality Assurance Commission and the Board of Osteopathic Medicine and Surgery will conduct a hearing at 7:00 p.m. on Wednesday, June 2, 2010. The Medical Quality Assurance Commission received petitions to add Alzheimer’s, chronic renal failure and neuropathic pain to the medical conditions for which medical marijuana would be beneficial and that are permitted under state law RCW 69.51A.010(4). The Medical Commission in consultation with the Osteopathic Board will determine whether the medical conditions submitted by the petitioners will be added to the Medical Marijuana Law. Hearing Location: Department of Health 310 Israel Road SE Tumwater, Washington 98501 (360) 236-2757 The Medical Commission and the Osteopathic Board committee invite written information from members of the public who are for or against adding the medical conditions to the Medical Marijuana Law. Written comments are to be submitted to the Medical Commission’s office no later than close of business on May 14, 2010, and will be provided to the committee for consideration prior to the June 2, 2010 hearing date. Written comments will be received by mail or in person at the Medical Commission’s office in Tumwater. Mailing Address: Maryella Jansen, Executive Director Medical Quality Assurance Commission P.O. Box 47866 Olympia, Washington 98504-7866 Physical Address: Maryella Jansen, Executive Director Medical Quality Assurance Commission 243 Israel Road SE Tumwater, Washington 98501 Oral testimony will be heard June 2, 2010, at 7:00 p.m. from members of the public who are for or against adding the conditions of Alzheimer’s, chronic renal failure and neuropathic pain as conditions for which medical marijuana would be beneficial and that are permitted under state law RCW 69.51A.010(4). The length of oral testimony may be limited by the committee. The committee will deliberate in closed session after the hearing to consider oral and written testimony. The committee will make a recommendation to the Medical Quality Assurance Commission and the Board of Osteopathic Medicine and Surgery to accept or deny the petitioners’ requests to add additional medical conditions to the Medical Marijuana Law. The Medical Commission and the Osteopathic Board will consider the committee’s recommendation and make a decision to accept or deny the petition. The decision will be announced at a later date due to the need for both the Medical Commission and the Osteopathic Board to discuss the hearing panel’s recommendation. For more information, email [email protected] or [email protected].

Add new comment

The content of this field is kept private and will not be shown publicly.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Permission to Reprint: This content is licensed under a modified Creative Commons Attribution license. Content of a purely educational nature in Drug War Chronicle appear courtesy of DRCNet Foundation, unless otherwise noted.